返回
Kuros Biosciences AG（CSBTF）價格
CSBTF 股價走勢圖
CSBTF 收益
Kuros Biosciences AG
$38.34
0%
$0
收盤價：Jan 16, 16:00:00 GMT-5
$38.34
0%
$0
盤後：Jan 16, 20:00:00 GMT-5
關鍵數據
前收市價
$38.34
開盤價
$38.34
當日範圍
$38.34 - $38.34
52週區間
$19.43 - $42.81
交易量
1.0K
平均成交量
63
每股盈餘 (TTM)
-0.19
股息收益率
--
市值
$1.4B
什麼是 CSBTF？
Kuros Biosciences Ltd. operates as biopharmaceutical company, which engages in developing products for tissue repair and bone regeneration. The company is headquartered in Schlieren, Zuerich and currently employs 122 full-time employees. The company went IPO on 2002-10-29. Immunodrugs are therapeutic vaccines intended for treating and preventing common chronic diseases, such as hypertension, nicotine addiction, allergic diseases, asthma, malignant melanoma and Alzheimer's disease. They are designed to instruct the patient's immune system to produce desired therapeutic antibody or T cell responses that modulate chronic disease processes. The firm has built a pipeline of different Immunodrug candidates, of which five are in clinical development. Its Immunodrug candidates are developed both in-house and together with Novartis, Pfizer and Pfizer Animal Health, among others. The firm has two subsidiaries: a wholly-owned Proteome Therapeutics GmbH and minority owned BioSupport AG.